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Food and Drug Administration (FDA, USA)-approved category B antibiotics are
commonly prescribed to treat infections during pregnancy. The aim of this study was
to investigate antibiotic-induced changes in gut microbiota (GM) that occur during
pregnancy. The 16S rRNA amplicon deep-sequencing method was used to analyze
the effect of category B antibiotics (azithromycin, amoxicillin and cefaclor) on GM during
pregnancy using a rat model. The GM composition was substantially modulated by
pregnancy and antibiotics administration. Firmicutes, Bacteroidetes, Proteobacteria,
Chlamydiae, Actinobacteria, and Cyanobacteria were the dominant phyla. Antibiotic
treatment during pregnancy increased the relative abundance of Proteobacteria and
reduced Firmicutes. The genera Shigella, Streptococcus, Candidatus Arthromitus, and
Helicobacter were significantly (p < 0.05) more abundant during pregnancy. Antibiotics
significantly (p < 0.05) reduced the relative abundance of Lactobacillus but increased
that of Enterobacter. There was a significant (p < 0.05) decrease in Lactobacillus
sp., Lactobacillus gallinarum and Lactobacillus crispatus during pregnancy. Antibiotic
treatment reduced bacterial diversity; the lowest number of operational taxonomic units
(OTUs) were detected in the cefaclor-treated groups. Antibiotics significantly (p < 0.05)
promoted weight gain during pregnancy, and increased relative abundance of Shigella
sonnei, Enterococcus hormaechei, and Acinetobacter sp. GM perturbations were
accompanied by increases in Proteobacteria abundance and weight gain in pregnancy
following antibiotic treatment.
Keywords: gut microbiota, azithromycin, amoxicillin, cefaclor, pregnancy, rats, 16S rRNA gene
INTRODUCTION
The gut microbiota (GM) is comprised of mutualistic microorganisms that reside in the host
gut (Dethlefsen and Relman, 2011). The majority of members of the human GM are bacteria
representing six dominant phyla: Firmicutes, Bacteroidetes, Proteobacteria, Verrucomicrobia,
Actinobacteria, and Fusobacteria (Ubeda and Pamer, 2012; Khan et al., 2014). These
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microorganisms play a crucial role in human digestion,
metabolism and immunity (Dethlefsen and Relman, 2011;
Ferreira et al., 2011). Several studies have associated alterations
in GM composition with serious health problems such as
diabetes, obesity, allergy, infection and inflammation (Bulloch
and Carroll, 2012; Ubeda and Pamer, 2012; Khan et al., 2014).
GM composition is plastic in nature and changes greatly with
age, diet, medication and physiological status (Dethlefsen and
Relman, 2011; Koren et al., 2012). Pregnant women were recently
reported to have an abnormal GM composition that changes
with trimester (Koren et al., 2012). Overall, GM diversity and
richness decrease with pregnancy (Koren et al., 2012). Pregnancy-
induced GM changes have been found to correlate with metabolic
disorder-like symptoms as demonstrated in a study in which
the intestines of germ-free mice were colonized with the GM of
pregnant women (Koren et al., 2012). Increases in the densities
of Proteobacteria and Actinobacteria during the third trimester
of pregnancy were found to be correlated with energy loss
in the stool (Koren et al., 2012; Hu et al., 2013). Moreover,
the density of beneficial bacteria, such as Faecalibacterium,
which has anti-inflammatory properties, is significantly reduced
during pregnancy (Koren et al., 2012). GM perturbations during
pregnancy increase the risk of infection, which can lead to
serious illnesses such as digestive problems and miscarriages
(Amann et al., 2006). These recent findings have motivated
researchers to investigate the associations between GM and
human health.
In past decades, it was assumed that the gastrointestinal
problems experienced by pregnant women, such as diarrhea,
hemorrhoids, stomach ache, acidity, headache, and vomiting,
were typical normal features of pregnancy. However, recent
studies have associated these symptoms with dysbiotic GM and
increasing risk of infection (Poveda et al., 2014; Shaban et al.,
2014). Poveda et al. (2014) observed that hyperemesis, dyspepsia
and gastric discomfort during pregnancy were associated with
Helicobacter pylori infection. It has been observed that many
pregnant women suffering from inflammatory bowel disease
(IBD) have lower bacterial diversity and a decreased density
of gut Enterobacteriaceae relative to pregnant women without
IBD (Poveda et al., 2014). A recent survey reported that
800 women die every day due to pregnancy complications,
including gastrointestinal infections (Say et al., 2014). Being
immune-compromised, pregnant women are more susceptible
to opportunistic pathogens (Petersen et al., 2010; Poveda et al.,
2014). The most common bacterial pathogens that induce acute
diarrhea in pregnant women are Shigella sp., Campylobacter
sp., Yersinia sp., Escherichia coli, and Salmonella sp. (Wald,
2003). A study using a non-human animal model found
that infections during pregnancy induced neuropathologies
and altered behavior (Amann et al., 2006; Hu et al., 2013).
In addition, the rapid increase in antibiotic resistance is
reducing the physician’s range of antibiotics that are considered
safe during pregnancy (Petersen et al., 2010; Hu et al.,
2013). Currently, physicians are mainly prescribing B-category
antibiotics that are recommended by the FDA, which are
considered to be non-teratogenic (Petersen et al., 2010). In
particular, increases in the use of beta-lactam antibiotics, e.g.,
penicillin and cephalosporin, during pregnancy have been
reported (Amann et al., 2006; Petersen et al., 2010). Amoxicillin
is the most commonly used antibiotic during pregnancy
(Amann et al., 2006; Petersen et al., 2010). Several studies have
reported modulation in GM-associated phyla (Actinobacteria,
Firmicutes, Bacteroidetes, and Proteobacteria) with broad-
spectrum antibiotic treatment (Ubeda et al., 2010; Claesson
et al., 2011; Murphy et al., 2013). Alterations of GM during
pregnancy could lead to pregnancy complications. The aim
of this study was to determine the impacts of pregnancy
and the antibiotics amoxicillin, cefaclor and azithromycin,
which are widely used during pregnancy, on GM in a
rat model. Total metagenomic DNA was extracted from
rat intestines and then subjected to 16S amplicon deep
sequencing to characterize the changes in GM diversity and
richness.
METHODOLOGY
Rat Model and Sample Collection
The research ethics committee of the Faculty of Medicine at
King Abdulaziz University approved the study protocol under
agreement number (HA-02-J-008). The experiment was carried
out in accordance with approved guidelines. Forty-eight sexually
mature, female Sprague–Dawley rats that were 8 weeks old
and weighed approximately 200–250 g were obtained from the
animal breeding unit of the King Fahd Medical Research Center
at King Abdulaziz University Jeddah, Saudi Arabia. The rats
were acclimatized to standardized laboratory conditions at a
temperature of 21 ± 1◦C, a relative humidity of 50 ± 10% and
a 12-h light–dark cycle. These environmental parameters were
maintained throughout the study. One week before conception,
the rats were housed in polycarbonate cages with hardwood chip
bedding. Conception for pregnant rats was confirmed through
detection of a vaginal plug. The first detection of sperm on
the plugs marked day D-0 of gestation. Rats have an average
gestational period of 21 days (Awodele et al., 2012). Antibiotics
suspensions were orally administered to rats on the 13th day of
gestation because the first 12 days of rat pregnancy are critical
for embryogenesis (Zalgevicˇiene˙, 2010; Er, 2013). The antibiotics
doses were selected based on human adult dosage, and converted
to rat dosage using body weight Ghosh’s formula. The following
dose of amoxicillin (50 mg/kg/day), azithromycin (45 mg/kg/day)
or cefaclor (67.5 mg/kg/day) was administered by oral gavage in
water suspension for 7 days (Ghosh, 2007; Gottberg et al., 2014).
Rats were divided into eight groups based on antibiotic treatment
and pregnancy: non-pregnant control (NPC) rats, pregnant
control rats (PC), non-pregnant rats treated with azithromycin
(NPAzi), pregnant rats treated with azithromycin (PAzi), non-
pregnant rats treated with amoxicillin (NPAmx), pregnant rats
treated with amoxicillin (PAmx), non-pregnant rats treated with
cefaclor (NPCef) and pregnant rats treated with cefaclor (PCef,
Supplementary Figure S1). Each group comprised six rats. All
rats were sacrificed on the 20th day of gestation, before delivery.
The intestinal sections were collected in sterile tubes. The samples
were stored at−80◦C for DNA extraction.
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16S rRNA Gene Sequencing and Data
Processing
Total metagenomic DNA was extracted from the intestinal
section using QIAamp Fast DNA Stool Mini Kit (Qiagen, USA).
The samples were sequenced for 16S rRNA genes targeting the
V4 region with barcoded 515F GTGCCAGCMGCCGCGGTAA
and 806R GGACTACVSGGGTATCTAAT universal primers
following the procedure of Dowd et al. (2008). DNA
concentrations were determined using the Qubit system
(Invitrogen, USA). Subsequently, dual-index barcodes and
Illumina sequencing adapters were joined to the reads using a
limited PCR cycle. After purification with Agencourt AMPure
beads (Agencourt, USA), libraries were normalized using the
Nextera XT protocol. Samples were pooled into a single flow
cell for sequencing on the MiSeq sequencing platform (Illumina,
USA) following the manufacturer’s protocol. Automated cluster
generation and paired-end sequencing with dual index reads
were performed in a single run with a read length of 2× 300 bp.
Raw FASTQ files were obtained from the Illumina MiSeq,
and paired end reads were collected using PANDAseq (Masella
et al., 2012). Sequences were cleaned of primers and barcodes.
Additionally, all reads with ‘N’ and those with sequences<200 bp
were deleted, and high-quality sequences were dereplicated
(Boissière et al., 2012). The cleaned sequences were then clustered
at k = 10 (97% similarity) followed by deletion of chimeras
and singleton reads (Eren et al., 2011; Swanson et al., 2011).
Finally, operational taxonomic units (OTUs) were classified using
BLASTn against a curated database derived from GreenGenes,
RDPII and NCBI. Sequence data of this study is submitted in the
NCBI under project no. PRJNA300497.
Statistical Analysis
The OTU biodiversity and richness were calculated using R
package phyloseq (1.7.24) implemented with non-parametric
Chao1 and rarefaction analysis that showed the uniformity
and distribution of OTUs in different groups (McMurdie and
Holmes, 2012). R package “rich” (0.3) was employed for
statistical modulations in specie richness and abundance. The
Kolmogorov–Smirnov D test was used to ascertain the normality
of the data. One-way ANOVA (for parametric data) and non-
parametric Kruskal–Wallis and Mann–Whitney tests (for non-
normal data) were performed to identify significantly different
bacterial taxa among different groups (Supplementary Figure S1).
SPSS version 22 was used for statistical analysis. The VassarStats
website1 was used to conduct pair-wise comparisons of rat weight
via the Tukey’s HSD test. The Shannon index was calculated using
the R statistical framework version 3.1.2 with VEGAN package
version 2.2-1.
RESULTS
Common Core Bacteria
In total, 5.7 million raw sequence reads were obtained using
the MiSeq system (Illumina, San Diego, CA, USA). After
1http://vassarstats.net/
filtration, approximately 5.6 million high quality (>250 bp)
sequence reads were obtained and assigned to bacterial domain.
Overall, 44 phyla were identified in the entire model system.
Thirty-three phyla were commonly found in each group, and
10 phyla were dominant at ≥1% concentration but varied in
relative abundance with pregnancy and antibiotic treatment. The
majority of sequencing reads were representative of the phyla
Firmicutes, Proteobacteria and Bacteroidetes, which dominated
the bacterial community in each of the studied groups. A total
of 292 families were detected. Among them, 120 families
were commonly present, and Clostridiaceae, Lactobacillaceae,
Helicobacteraceae, Streptococcaceae, and Bacillaceae were the
dominant families detected. A total 788 OTUs were identified
at the genus level. The highest number of genera (591)
was detected in pregnant control (PC), whereas the lowest
(505) was found in non-pregnant rats treated with cefaclor
(NPCef). Antibiotics significantly decreased the number of
genera in non-pregnant rats treated with azithromycin (NPAzi,
p = 0.008, 529), non-pregnant rats treated with amoxicillin
(NPAmx, p= 0.012, 525) and NPCef (p = 0.002, 506) relative
to the number in NPC. The Clostridium and Shigella were the
dominant genera associated with pregnancy. We observed 1466
different species; approximately 1316 species were shared in
common among the rat groups, and 150 were species unique to
one or more groups. The highest number of species was observed
in PC (1056) followed by NPC (1046). The lowest species
diversity was observed in pregnant rats treated with cefaclor
(PCef, 903) (Figure 1). Species diversity substantially decreased
with antibiotic treatment in both pregnant and non-pregnant rat
groups. In particular, significantly decreased (p= 0.05; p= 0.018)
species diversity was observed among cefaclor treated pregnant
and non-pregnant rats (Supplementary Figure S2). The effect of
amoxicillin on OTUs richness was also severe, which was more
severe (p = 0.036) during pregnancy (PAmx). In term of OTUs
diversity, azithromycin was least damaging among the tested
antibiotics. Among the dominant bacterial species, Lactococcus
lactis, Bacillus thermoamylovorans, and Clostridium sp. were
commonly abundant in all groups.
Gut Microbiota Differences between
Pregnant and Non-pregnant Control
Groups
Percentage of the dominant phyla modulated with pregnancy
however the change was statistically insignificant. Percentage
relative abundance of the phyla Firmicutes, Bacteroidetes,
and Tenericutes was decreased in PC compared with NPC.
The density of Proteobacteria was increased in pregnant rats
relative to non-pregnant rats (Figure 2). The GM of the
NPC group was predominantly composed of the families
Lactobacillaceae (24.9 ± 5.48%), Clostridiaceae (18.6 ± 4.6%),
Streptococcaceae (13.9 ± 5.2%), Bacillaceae (7.5 ± 5.4%) and
Helicobacteraceae (7.2 ± 2.7%). Comparatively, the density of
Clostridiaceae (30.4 ± 8.6%), Helicobacteraceae (12 ± 6.75%),
Erysipelotrichaceae (3.1 ± 1.5%) and Enterobacteriaceae
(14.3 ± 3.6%) was increased in PC. The concentrations
of Lactobacillaceae (16.4 ± 7.5%) and Streptococcaceae
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FIGURE 1 | Operational taxonomic units (OTUs) presentation and analysis at specie level. Network presentation of OTUs at the species level among the
groups. Species shared among different groups are connected by multiple threads, whereas unique bacterial OTUs are connected to their respective groups by a
single line. NPC, non-pregnant control; PC, pregnant control; NPAzi, non-pregnant rats exposed to azithromycin; PAzi, pregnant rats exposed to azithromycin;
NPAmx, non-pregnant rats exposed to amoxicillin; PAmx, pregnant rats exposed to amoxicillin; NPCef, non-pregnant rats exposed to cefaclor; PCef, pregnant rats
exposed to cefaclor.
(6.64± 2.3%) were decreased in PC relative to the corresponding
values in NPC (Figure 3). Shigella (2.1 ± 0.55%), Streptococcus
(2.06 ± 0.89%), Candidatus Arthromitus (0.9 ± 0.06%) and
Helicobacter (12 ± 3.6%) abundance significantly (p < 0.05)
increased with pregnancy relative to NPC (Figure 4).
Lactobacillus was the dominant genus (24%) in NPC and
comprised 27 species. Clostridium sp. (21.09± 8.02) significantly
(p = 0.04) increased in relative abundance with pregnancy,
and the concentrations of Helicobacter rodentium (5.4 ± 1.13),
Turicibacter sp. (3.1 ± 1.3), Helicobacter apodemus (4.49 ± 1.35)
and Streptococcus hyointestinalis (1.48± 0.71) also increased with
pregnancy. We observed a significant decline in Lactobacillus sp.
(p = 0.037, 0.79 ± 0.3) and Lactobacillus gallinarum (p = 0.022,
0.43 ± 0.06) in PC relative to NPC (Figure 5). Lactococcus
lactis, Lactobacillus johnsonii, Shigella sonnei, Clostridium sp.,
Turicibacter sp. and Helicobacter apodemus had higher relative
abundances in PC than in NPC (Figure 5).
Gut Microbiota Alteration in Response to
Azithromycin
In the NPAzi and PAzi groups, azithromycin treatment reduced
the density of Firmicutes but increased that of Proteobacteria
(Figure 2). Azithromycin significantly enriched the families
Enterobacteriaceae (p = 0.023) and Staphylococcaceae
(p = 0.031) and decreased that of Streptococcaceae in the
NPAzi and PAzi groups. The family Erysipelotrichaceae was
significantly (p = 0.004) enriched in the PAzi group, and
Helicobacteraceae (p = 0.001) concentration decreased in
NPAzi. Azithromycin significantly decreased the relative
abundance of Lactobacillaceae (p = 0.0016) in the NPAzi and
PAzi groups (Figure 3). There were significant increase in
abundance of the genera Turicibacter (p = 0.003) and decrease
of Candidatus Arthromitus (p = 0.002) in PAzi relative to PC,
whereas Lactobacillus (p = 0.002) decreased in both NPAzi and
PAzi relative to PC and NPC. Additionally, the genera Shigella
(p = 0.037), Advenella (p = 0.006) and Stenotrophomonas
(p = 0.009) were significantly enriched in PAzi. Azithromycin
significantly decreased Campylobacter (p = 0.007) and enriched
Mitsuaria (p = 0.035) and Enterobacter (0.026) in NPAzi
compared with NPC (Figure 4).
Azithromycin reduced bacterial species diversity, and the
effect was more marked in NPAzi (928), with an 11.2% decrease
in OTUs relative to NPC (1046). The total OTU count was
976 in PAzi (Figure 1). Moreover, azithromycin caused an
increase in the number of dominant species (≥1%) to 19 in
both the NPAzi and PAzi groups relative to the NPC and PC
groups, which had 15 and 13 dominant species, respectively.
Among the dominant species, only Clostridium sp., L. lactis
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FIGURE 2 | Average relative density of the dominant bacterial phyla. The x-axis shows the taxon groups, and the y-axis displays the average percentages of
sequences reads. The cutoff point for selecting the dominant phyla was set to ≥1%. “Others” indicates minor phyla. Abbreviations are as described for Figure 1.
FIGURE 3 | Comparative analysis of the dominant and significantly different families in the gut microbiota of control versus pregnant and
antibiotic-treated rat groups. The densities are shown in average percentage. The direction of arrow is indicating increase or decrease in the density of each
family in compare to respective control. The color of steric represents significant changes in the respective group. ∗ Indicates significant at p < 0.05. ∗∗ Indicates
highly significant at p ≤ 0.01. Abbreviations are as described for Figure 1.
and B. thermoamylovorans were common to both in NPAzi
and NPC. Sphingomonas sp., H. cholecystus and Streptococcus
hyointestinalis were dominant in the PC group and decreased in
PAzi. In addition, NPAzi and PAzi were colonized by 14 and 18
unique bacteria, respectively. We observed significant increases
in Shigella sonnei (p= 0.037), Advenella kashmirensis (p= 0.006),
Lactobacillus kalixensis (p = 0.007) and Peptoclostridium
clostridium difficile (p = 0.001) relative to PC. Helicobacter
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FIGURE 4 | Comparative analysis of the dominant and significantly different genera in the gut microbiota of control versus pregnant and
antibiotic-treated rat groups. The color of steric (∗) represents significant change in the respective groups. ∗ Indicates significant at p < 0.05. ∗∗ Indicates highly
significant at p ≤ 0.01. Abbreviations are as described for Figure 1.
apodemus (NPAzi), Lactobacillus johnsonii (NPAzi and PAzi),
Bacillus thermoamylovorans (PAzi), and Lactobacillus gasseri
(NPAzi and PAzi) decreased significantly following azithromycin
treatment (Figure 5). Azithromycin increased Turicibacter sp.
(17.7± 7.5%) in pregnant rats; this taxon had relative abundances
of 3.11± 1.09% and 2.07± 1.02% in NPC and PC, respectively.
Gut Microbiota Alteration in Response to
Amoxicillin
Amoxicillin increased Proteobacteria density and reduced that of
Firmicutes in both NPAmx and PAmx (Figure 2). The families
Clostridiaceae (p= 0.009) and Lactobacillaceae (p= 0.004) signi-
ficantly decreased whereas Enterobacteriaceae (p = 0.001)
increased in both NPAmx and PAmx. We also observed
a significant increase in Rhabdochlamydiaceae (p= 0.042),
Chitinophagaceae (p = 0.024), Cytophagaceae (p = 0.011),
Methylobacteriaceae (p = 0.013), Burkholderiales (p = 0.01),
Comamonadaceae (p = 0.007), Caulobacteraceae (p = 0.012),
and Moraxellaceae (p = 0.009) in the NPAmx group (Figure 3).
Similarly, the genera Enterobacter (p = 0.003) and Shigella
(p = 0.001) significantly increased, and Lactobacillus (p = 0.004)
and Clostridium (p = 0.019) decreased in both groups (NPAmx
and PAmx) (Figure 4). As with azithromycin treatment, a
profound decrease in bacterial diversity was observed in the
amoxicillin-treated groups NPAmx (12.4%) and PAmx (9.8%)
compared with NPC. There were 14 distinct species detected in
NPAmx and 20 detected in PAmx (Figure 1). The diversity of
the dominant species (≥1% concentration) was higher in NPAmx
(20 species) than in PAmx (12 species); the corresponding values
in NPC and PC were 15 and 13, respectively. Amoxicillin
significantly (p = 0.001) increased Shigella sonnei. Moreover,
the dominant species in PAmx were Lactococcus lactis and
Clostridium sp. (Figure 5).
Gut Microbiota Alteration in Response to
Cefaclor
The smallest changes in Firmicutes and Proteobacteria density
with antibiotic treatment were observed in the cefaclor groups
(NPCef and PCef) (Figure 2). Cefaclor significantly decreased
Helicobacteraceae (p = 0.01) and increased Methylobacteriaceae
(p = 0.009), Enterobacteriaceae (p = 0.002) and Moraxellaceae
(p = 0.003) in both NPCef and PCef (Figure 3). In addition,
Lactobacillaceae (p = 0.008) and Mycoplasmataceae (p = 0.045)
were significantly reduced in NPCef. We observed a significant
(p ≤ 0.01) increase in the genera Lactococcus, Shigella,
Enterobacter, and Methylobacterium in the PCef group (Figure 4).
Collectively, 30 distinct bacteria species were detected in the
NPCef and PCef groups (Figure 1). The most dominant species
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FIGURE 5 | Heat map of the dominant and significantly different
species in the gut microbiota of control versus pregnant and
antibiotic-treated rat groups. The stearic represents significant change in
respective group. ∗ Indicates significant at p < 0.05. ∗∗ Indicates highly
significant at p ≤ 0.01. Abbreviations are as described for Figure 1.
was Lactococcus lactis in NPCef (38 ± 7.2%), but its relative
abundance was reduced to 13.9± 4.7% in PCef. Furthermore, the
predominant species in PCef were Lactococcus lactis, Clostridium
sp. (10.42 ± 4.23%), Lactobacillus johnsonii (12.35 ± 2.21%) and
Bacillus thermoamylovorans (6.68± 3.23%) (Figure 5).
Biodiversity and Microbial Richness
Alpha diversity was estimated through rarefaction analysis,
the Shannon index and the Chao1 index. The lowest OTU
richness was observed in the cefaclor-treated groups (NPCef
and PCef). The highest Chao1 value was observed for PC
followed by NPC and PAzi. Rarefaction analysis indicated
variation among samples and showed sufficient data coverage
for diversity in the samples (Supplementary Figure S3). The
Shannon Wiener index, calculated at 3% dissimilarity, showed
the lowest value of evenness (2.8) for NPCef. The highest
value of evenness was observed for NPAzi (4.4) and NPAmx
(4.2). The identified genera from all sequence reads were
compared using UPGMA distance matrix clustering analysis.
The pregnant groups treated with antibiotics formed a separate
cluster from the non-pregnant groups (Supplementary Figure
S4). Similarly, the multivariate principal coordinate data
analysis separated the pregnant and non-pregnant groups.
NPcef showed more divergence than did the other groups
(Figure 6).
Antibiotic-Induced Weight Gain and
Associated GM Changes
Rats were weighed on D-0 and at the time of sacrifice. The D-
0 weight was subtracted from final weight to observe relative
weight gain. Among the non-pregnant, antibiotic-treated rat
groups, weight gain was significant (p = 0.00) between these
two time points in the NPCef group (21.4 ± 2.27 g). Among
the pregnant groups, significant (p < 0.05) weight gain was
observed in PAzi (82.3 ± 1.9 g), PAmx (99.3 ± 4.7 g) and
PCef (79.1 ± 4.5 g) in comparison with PC (69.5 ± 1.7 g,
Supplementary Figure S5). In the pregnant, antibiotic-treated
rats, the family Enterobacteriaceae and the species Shigella
sonnei were the only taxa with significant increases in relative
abundance relative to PC. Higher densities of Proteobacteria
and Bacteroidetes were detected in pregnant rats treated with
antibiotics in comparison to PC (Figure 2). Several studies have
associated increasing levels of E. coli with weight gain (Collado
et al., 2008; Chichlowski and Hale, 2009; Evans et al., 2014). We
observed that antibiotic treatment promoted the growth of E. coli
in pregnant rats. Moreover, Shigella, which was significantly
increased in the antibiotic-treated pregnant rat groups, is very
closely related to Escherichia and difficult to distinguish from
Escherichia based on 16S amplicon sequencing.
DISCUSSION
Pregnancy accompany with GM remodeling that participate in
modulating host metabolism and other physiological changes
(Koren et al., 2012). These modulations could be supportive in
fetal nourishment, however, few in-depth data is published to
comprehend GM role in this critical time. In this study, we
adopted a 16S rRNA amplicon deep sequencing approach to
analyze the antibiotic-induced changes in GM that occur during
pregnancy. We observed that majority of dominant taxa were
similar with modulated abundances between NPC and PC. The
abundance of Firmicutes profoundly impacted during pregnancy
that could be related to reduction in the abundance of health
promoting families, such as Lactobacillaceae, Streptococcaceae,
and Bacillaceae. These taxa have probiotic abilities against various
types of diarrhea, functional abdominal pain, ulcerative colitis
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FIGURE 6 | The multivariate principal coordinate data analysis of the groups using type-1 scaling. The projecting vectors represent groups and their
variability. The colored points labeled with species names show enrichment along respective groups. ∗ Indicates significant at p < 0.05. ∗∗ Indicates highly significant
at p ≤ 0.01. Abbreviations are as described for Figure 1.
and digestive problems (Hanning et al., 2010; Aagaard et al.,
2012). Dysbiosis in these groups may be one of the reasons
behind GIT problems during pregnancy. However, in exception,
family Clostridiaceae enriched during pregnancy which is in
agreement with Aagaard et al. (2012). Clostridiaceae is butyrate-
producing family that improves intestinal lining and help
colonocytes in energy extraction. The absence of butyrate can
lead to dysfunctional intestinal architecture which could be easily
breached by intestinal bacteria and molecules in the bloodstream
(Lecomte et al., 2015). Like Koren et al. (2012) we observed
substantial reduction in the abundance of Proteobacteria during
pregnancy. Proteobacteria enrichment has been associated with
increasing inflammation level during pregnancy (Koren et al.,
2012). A single member (E. coli) of Proteobacteria is sufficient to
induce inflammation and disturb glucose and insulin tolerance
in germ free mice (Caesar et al., 2012). Several other studies
have documented pregnancy-induced changes in GM density
and composition, especially the aberrant ratio of Proteobacteria
to Firmicutes (De La Cochetiere et al., 2005; Yap et al., 2008;
Antonopoulos et al., 2009; Dethlefsen and Relman, 2011). As
GM is actively involved in host digestion and metabolism,
we suggest in correlating modulated GM composition and
richness with metabolomics that could help to understand
metabolic complication during pregnancy. Interestingly, based
on our literature review using PubMed, this study provides
the first detection of the phyla Ignavibacteriae, Thermotogae,
Candidatus Saccharibacteria, Dictyoglomi, and Acetothermia
in the rat GM. Detection of these phyla could be attributed
to the deep 16S amplicon sequencing. Moreover, bacterial
diversity enriched during pregnancy in comparison to NPC
which could be beneficial in term of GM inheritance to infants;
as diversified GM has been associated with lower risks of
allergic reactions in infants (Rautava et al., 2012; Zijlmans et al.,
2015).
Antibiotics substantially reduced species diversity; as
broad-spectrum antibiotics disrupt microbial balance, affecting
pathogenic as well as host-associated microbes (Heinsen et al.,
2015). The lowest species diversity was observed in the PCef
group. Cefaclor is the second-generation cephalosporin with
broad spectrum properties (Tomic´ et al., 2016) against aerobe
and anaerbe bacteria (Mangla and Aggarwal, 2012). The wide
range of antimicrobial ability of cefaclor may be one of the
reasons behind drastic reduction in OTUs diversity in cefaclor
treated groups. Amoxicillin also profoundly reduced species
diversity, however, the effect was significant during pregnancy.
Additionally, the percentage relative abundances of dominant
phyla changed following antibiotic treatment compared with
their levels in PC and NPC. Moreover, antibiotics effects toward
individual species were different. For instance, amoxicillin
and azithromycin clearly reduced abundance of Lactobacillus
johnsonii. However, cefaclor enriched Lactobacillus johnsonii in
PCef. Lactobacillus johnsonii is probiotics bacteria, inhabits the
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upper part of gastrointestinal tract, actively participates in bile
acid hydrolysis and assists the host in combating Helicobacter
pylori infections (Pantoflickova et al., 2003; Aagaard et al., 2012).
Antibiotics-induced changes to the composition or metabolism
of microbiota may adversely affect pregnancy outcomes and
could lead to pregnancy complications (Zhang et al., 2015).
Therefore, we suggest screening of other category B antibiotics
for GM richness and abundance to ensure minimum damage to
beneficial flora.
We noticed that antibiotics treatment enriched the abundance
of opportunistic pathogens, especially in genera Enterobacter,
Shigella, Helicobacter, and Clostridium that could be related
to Firmicutes/Proteobacterial aberration. All these modulated
taxa are positively correlated with weight gain in pregnant
groups. Several others studies have also documented modulated
abundances of some of these taxa with weight gain (Cani
et al., 2007; Santacruz et al., 2010; Koren et al., 2012). The
gram-negative bacteria have been reported to induce weight
by elevating endotoxin and inflammatory markers level (Cani
et al., 2007; Santacruz et al., 2010). Furthermore, probiotic
bacteria, such as Lactobacillus species, declined with antibiotics
treatment that is inversely correlated with weight gain (Yasir
et al., 2015). L. reuteri strain ATCC PTA 4659 has the potentials
to prevent host from diet-induced obesity (Fak and Backhed,
2012).
In contrast to the findings of Lecomte et al. (2015), we
found that the rat gastrointestinal tract was dominated by
Lactobacillus intestinalis. Similarly, the predominant GM species
in the NPC group were Clostridium sp. and Lactococcus lactis
followed by Lactobacillus johnsonii, Bacillus thermoamylovorans
and Lactobacillus kalixensis. The differences between the two
studies could be due to differences in experimental procedure
and sequencing methodology. Since GM composition is plastic
in nature and can also fluctuate with geological differences
(Quercia et al., 2014). Some of the detected species are water
dwelling species, i.e., Hydrotalea flava and Pelomonas aquatica
that enriched with amoxicillin treatment in non-pregnant rats.
It is normal to isolate bacteria from unusual habitat, for instance
Pelomonas has been recently reported in human stomach (Yang
et al., 2016).
Overall, antibiotics administration during pregnancy
decreased bacterial diversity and promoted weight gain in
particular with cefaclor treatment. Relative abundance of
beneficial bacteria from Lactobacillus group associated with
the host metabolism were decreased, and growth of several
opportunistic pathogenic species were increased. Different
classes of antibiotics produced varying effects on maternal GM
composition during pregnancy and providing potential clues
to aid in the clinical selection of antibiotics. In conclusion,
antibiotics that are commonly prescribed during pregnancy
should be analyzed for microbiome to understand maternal
dysbiosis-related body maladaptation and associated pregnancy
complications.
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